Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including SARS-CoV-2.
Lactiga has earned awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.
Location: United States, New Jersey
Member count: 1-10
Total raised: $1.6M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Checkmate ... | checkmatec... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.09.2022 | Pre-Seed | $1.6M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 22.09.2022 | Lactiga Th... | Lactiga Therapeutics, a North ... | Canada US... | - | finsmes.co... |
| 21.09.2022 | Lactiga Th... | NORTH BRUNSWICK, N.J., Sept. 2... | - | - | globenewsw... |
| 21.09.2022 | Lactiga Th... | /EIN News/ -- NORTH BRUNSWICK,... | - | - | einpresswi... |
| - | Lactiga | “Lactiga™ is an award-winning,... | - | - | fastfounde... |